Demo Data from SIGIR 2026 / reviewers in the wild / expert
Brad Reisfeld
dblp:79/9063
· DBLP profile ↗
2ranked-venue papers
2as first author
1since 2021 · last 2022
0000-0003-1310-1495ORCID · verified
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 2 · 2 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
2 papers |
Bioinformatics and computational biology · 100% |
Topics — the 1 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › molecular property prediction › predictive toxicology
carcinogenicity prediction |
0.6 | 1 | 2022 | kc-hits: a tool to aid in the evaluation and classification of chemical carcinogens · Bioinform. 2022 |
Methods — techniques the papers use, named apart from their topics
reverse dosimetry · 0.2forward dosimetry · 0.2
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2022 | kc-hits: a tool to aid in the evaluation and classification of chemical carcinogensabstractMOTIVATION: The evaluation of chemicals for their carcinogenic hazard requires the analysis of a wide range of data and the characterization of these results relative to the key characteristics of carcinogens. The workflow used historically requires many manual steps that are labor-intensive and can introduce errors, bias and inconsistencies. RESULTS: The automation of parts of the evaluation workflow using the kc-hits software has led to significant improvements in process efficiency, as well as more consistent and comprehensive results. AVAILABILITY AND IMPLEMENTATION: https://gitlab.com/i1650/kc-hits.git. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Brad Reisfeld, Aline de Conti, Fatiha El Ghissassi, Lamia Benbrahim-Tallaa, William Gwinn, Yann Grosse, Mary Schubauer-Berigan |
Bioinform. | 1 |
| 2013 | DoseSim: a tool for pharmacokinetic/pharmacodynamic analysis and dose reconstructionabstractUNLABELLED: Assessing and improving the safety of chemicals and the efficacy of drugs depends on an understanding of the biodistribution, clearance and biological effects of the chemical(s) of interest. A promising methodology for the prediction of these phenomena is physiologically based pharmacokinetic/pharmacodynamic modeling, which centers on the prediction of chemical absorption, distribution, metabolism and excretion (pharmacokinetics) and the biological effects (pharmacodynamics) of the chemical on the organism. Strengths of this methodology include modeling across multiple scales of biological organization and facilitate the extrapolation of results across routes of exposure, dosing levels and species. It is also useful as the foundation for tools to (i) predict biomarker levels (concentrations of chemical species found in the body that indicate exposure to a foreign chemical), given a chemical dose or exposure; (ii) reconstruct a dose, given the levels of relevant biomarkers; and (iii) estimate population variability. Despite the importance and promise of physiologically based pharmacokinetic /pharmacodynamics-based approaches to forward and reverse dosimetry, there is currently a lack of user-friendly, freely available implementations that are accessible and useful to a broad range of users. DoseSim was developed to begin to fill this gap. AVAILABILITY: The application is available under the GNU General Public License from http://scb.colostate.edu/dosesim.html. Brad Reisfeld, Jaime H. Ivy, Michael A. Lyons, Jesse M. Wright, Justin L. Rogers, Arthur N. Mayeno |
Bioinform. | 1 |